Improved Mitral Valve Performance After Transapical Aortic Valve Implantation Martin Haensig, MD, David Michael Holzhey, MD, PhD, Michael Andrew Borger, MD, PhD, Axel Linke, MD, PhD, Joerg Seeburger, MD, PhD, Sven Lehmann, MD, PhD, Gerhard Schuler, MD, PhD, Friedrich-Wilhelm Mohr, MD, PhD The Annals of Thoracic Surgery Volume 97, Issue 4, Pages 1247-1254 (April 2014) DOI: 10.1016/j.athoracsur.2013.11.025 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Degree of mitral regurgitation (MR) after transapical aortic valve implantation (TA-AVI) and follow-up in patients with MR at baseline. The Annals of Thoracic Surgery 2014 97, 1247-1254DOI: (10.1016/j.athoracsur.2013.11.025) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 New York Heart Association (NYHA) functional class at baseline and follow-up in patients with mitral regurgitation (MR) after transapical aortic valve implantation (TA-AVI). The Annals of Thoracic Surgery 2014 97, 1247-1254DOI: (10.1016/j.athoracsur.2013.11.025) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier survival analysis for all-cause mortality in patients with mild or trivial versus moderate or severe mitral regurgitation (MR) at baseline. The hazard ratios (HRs) for in-hospital and 4-year mortality were risk adjusted with regard to age, atrial enlargement, myocardial infarction, mean transaortic gradient, left ventricular ejection fraction (LVEF), logistic EuroSCORE, and Society of Thoracic Surgeons (STS) score. The Annals of Thoracic Surgery 2014 97, 1247-1254DOI: (10.1016/j.athoracsur.2013.11.025) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions